Search results for “Factor VIIIa” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 141 patents, we discovered top 37 key players by total patent application. Bristol Myers Squibb Co., Kymab Ltd., Immuno AG are dominant in this area. They take 29.79% of the total patent filing.
Bristol Myers Squibb Co.
New York, United States
Patent: 20
Kymab Ltd.
Cambridgeshire, United Kingdom
Patent: 11
Immuno AG
Austria
Patent: 11
Novo Nordisk A/S
Hovedstaden, Denmark
Patent: 9
Novartis AG
Basel-Stadt, Switzerland
Patent: 7
Octapharma AG
Schwyz, Switzerland
Patent: 7
CSL Behring GmbH
Hessen, Germany
Patent: 7
Baxter International, Inc.
Illinois, United States
Patent: 6
Baxter Healthcare SA
ZURICH, Switzerland
Patent: 6
STARTUP
Anthos Therapeutics, Inc.
Massachusetts, United States
Patent: 6
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 9 patents, we discovered top 3 start-ups by total patent application.
STARTUP
Anthos Therapeutics, Inc.
Massachusetts, United States
Patent: 6
STARTUP
Eio Biomedical Ltd.
Israel
Patent: 2
STARTUP
Freeline Therapeutics Ltd.
Herefordshire, United Kingdom
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 37 patents applied in the last 5 years. We discover 16 most active companies in this area. The fast-growing Kymab Ltd., Anthos Therapeutics, Inc., Board of Trustees of the Leland Stanford Junior University take 56.76% of patent filing during this period.
Kymab Ltd.
Cambridgeshire, United Kingdom
Patent: 11
STARTUP
Anthos Therapeutics, Inc.
Massachusetts, United States
Patent: 6
Board of Trustees of the Leland Stanford Junior University
California, United States
Patent: 4
Novartis AG
Basel-Stadt, Switzerland
Patent: 3
U.S. Department of Veteran Affairs
District of Columbia, United States
Patent: 3
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 3
Baxalta, Inc.
Illinois, United States
Patent: 2
Suzhou Ruibo Biological Technology Co Ltd
Jiangsu Sheng, China
Patent: 1
STARTUP
Freeline Therapeutics Ltd.
Herefordshire, United Kingdom
Patent: 1
Baxalta GmbH
ZURICH, Switzerland
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 37 patents in last 5 years, we discover 12 new entrants. Kymab Ltd., Anthos Therapeutics, Inc., Board of Trustees of the Leland Stanford Junior University are the most active new entrants in this area.
Kymab Ltd.
Cambridgeshire, United Kingdom
Patent: 11
STARTUP
Anthos Therapeutics, Inc.
Massachusetts, United States
Patent: 6
Board of Trustees of the Leland Stanford Junior University
California, United States
Patent: 4
U.S. Department of Veteran Affairs
District of Columbia, United States
Patent: 3
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 3
Suzhou Ruibo Biological Technology Co Ltd
Jiangsu Sheng, China
Patent: 1
Green Cross Corp.
South Korea
Patent: 1
STARTUP
Freeline Therapeutics Ltd.
Herefordshire, United Kingdom
Patent: 1
Mogam Institute For Biomedical Research
Chungcheongnam-do, South Korea
Patent: 1
Gladiator Biosciences, Inc.
United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 37 patents, we discovered top 3 universities and scientific research institutions by total patent application.
University of Rochester
New York, United States
Patent: 16
University of Leiden
Zuid-Holland, Netherlands
Patent: 10
St. Louis University
Missouri, United States
Patent: 6
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: